Todd C. Brady - 28 Feb 2023 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
President and CEO, Director
Signature
/s/ Todd C. Brady
Issuer symbol
ALDX
Transactions as of
28 Feb 2023
Transactions value $
$0
Form type
4
Filing time
02 Mar 2023, 15:22:33 UTC
Previous filing
19 Jul 2022
Next filing
11 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Award $0 +239K +19.63% $0.00 1.46M 28 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (right to buy) Award $0 +250K $0.00 250K 28 Feb 2023 Common Stock 250K $6.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
F2 The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2023.